English
简体中文
Total: £ 56.28
Published Date: 2025-12-11 | Pages: 92 | Tables: 94 | Medical Devices & Consumables
The global market for Irreversible Electroporation (IRE) was valued at US$ 155 million in the year 2024 and is projected to reach a revised size of US$ 222 million by 2031, growing at a CAGR of 5.2% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Irreversible Electroporation (IRE) competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Irreversible Electroporation (IRE) is a non-thermal medical procedure that utilizes electrical pulses to induce permanent cell membrane permeabilization, leading to cell death. This technique involves delivering short bursts of high-voltage electric fields to targeted tissues, disrupting the cellular membranes and allowing for the entry of ions and small molecules. IRE is particularly useful in the treatment of tumors, as it can selectively ablate cancerous cells while minimizing damage to surrounding healthy tissues. It is often used in conjunction with imaging techniques for precise targeting, making it a promising option for treating various malignancies, especially in delicate areas like the pancreas or liver. IRE is considered advantageous due to its ability to preserve extracellular structures and maintain vascular integrity, resulting in fewer complications and improved healing compared to traditional thermal ablation methods. The price of an IRE mainframe is approximately several hundred thousand US dollars, with an annual production capacity of about 400 units.
The upstream of an Irreversible Electroporation (IRE) device includes the development and production of high-voltage pulse generators, precision electrode probes, insulated cabling, electronic control systems, imaging guidance systems (ultrasound, CT, or MRI), and software for treatment planning and real-time monitoring. It also relies on biocompatible materials for electrodes, robust manufacturing of medical-grade electronics, and compliance with regulatory standards. The downstream side consists of hospitals, oncology centers, and interventional radiology clinics that use IRE devices for minimally invasive tumor ablation, often combined with imaging systems and surgical planning workflows. Supporting services include training, device maintenance, and clinical support provided by manufacturers or distributors. In summary, IRE devices connect upstream high-voltage electronics, electrode engineering, and medical-grade materials with downstream clinical facilities and service networks, forming a value chain that integrates precision engineering, healthcare delivery, and regulatory compliance.
The market for Irreversible Electroporation (IRE) devices is being driven by the growing demand for minimally invasive tumor ablation technologies that offer precise tissue targeting while sparing surrounding critical structures. IRE is increasingly recognized as an effective option for treating tumors in sensitive anatomical locations, such as the pancreas, liver, and prostate, where traditional thermal ablation carries higher risk of collateral damage. Advances in imaging integration, electrode design, and pulse-control software are enhancing procedural accuracy, expanding the range of treatable tumor types, and improving patient outcomes. Hospitals and specialized oncology centers are adopting IRE as part of a broader trend toward precision interventional oncology, emphasizing outpatient procedures, reduced recovery times, and improved quality of life. Additionally, regulatory approvals and clinical guideline endorsements in multiple regions are fostering greater clinician confidence, while ongoing research into combination therapies with immunotherapy and chemotherapy is positioning IRE devices as a versatile tool in the evolving cancer treatment landscape. Overall, the sector reflects a technology-driven, clinically focused market that is gradually moving from niche adoption toward mainstream interventional oncology practice.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Irreversible Electroporation (IRE), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Irreversible Electroporation (IRE).
The Irreversible Electroporation (IRE) market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Irreversible Electroporation (IRE) market comprehensively. Regional market sizes, concerning products by Type, by Application, by Guidance System and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Irreversible Electroporation (IRE) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Guidance System and by regions.
By Company
AngioDynamics
Pulse Biosciences
Biosense Webster (J&J)
Medtronic
Boston Scientific
Surgnova
Nortion REMD
Tianjin Alp Medical Technology
Sichuan Jinjiang Electronic Medical Device Technology
Tianjin Intelligent Health Medical
Shineyo Medical
Zhouling Medical Equipment
Aikemai Medical Equipment
Hangzhou Nuomao Medical Technology
APT Medical
Segment by Type
IRE Devices
IRE Catheters
Segment by Guidance System
2D Guidance
3D Guidance
Segment by End User
Hospitals
Ambulatory Surgical Centers
Segment by Application
Tumors
Cardiac Diseases
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Irreversible Electroporation (IRE) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Irreversible Electroporation (IRE) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Irreversible Electroporation (IRE) Market Overview
1.1 Product Definition
1.2 Irreversible Electroporation (IRE) by Type
1.2.1 Global Irreversible Electroporation (IRE) Market Value Comparison by Type (2024 VS 2031)
1.2.2 IRE Devices
1.2.3 IRE Catheters
1.3 Irreversible Electroporation (IRE) by Guidance System
1.3.1 Global Irreversible Electroporation (IRE) Market Value Comparison by Guidance System: 2024 VS 2031
1.3.2 2D Guidance
1.3.3 3D Guidance
1.4 Irreversible Electroporation (IRE) by End User
1.4.1 Global Irreversible Electroporation (IRE) Market Value Comparison by End User: 2024 VS 2031
1.4.2 Hospitals
1.4.3 Ambulatory Surgical Centers
1.5 Irreversible Electroporation (IRE) by Application
1.5.1 Global Irreversible Electroporation (IRE) Market Value by Application (2024 VS 2031)
1.5.2 Tumors
1.5.3 Cardiac Diseases
1.6 Global Irreversible Electroporation (IRE) Market Size Estimates and Forecasts
1.6.1 Global Irreversible Electroporation (IRE) Revenue 2020-2031
1.6.2 Global Irreversible Electroporation (IRE) Sales 2020-2031
1.6.3 Global Irreversible Electroporation (IRE) Market Average Price (2020-2031)
1.7 Assumptions and Limitations
2 Irreversible Electroporation (IRE) Market Competition by Manufacturers
2.1 Global Irreversible Electroporation (IRE) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Irreversible Electroporation (IRE) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Irreversible Electroporation (IRE) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Irreversible Electroporation (IRE), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Irreversible Electroporation (IRE), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Irreversible Electroporation (IRE), Product Type & Application
2.7 Global Key Manufacturers of Irreversible Electroporation (IRE), Date of Enter into This Industry
2.8 Global Irreversible Electroporation (IRE) Market Competitive Situation and Trends
2.8.1 Global Irreversible Electroporation (IRE) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Irreversible Electroporation (IRE) Players Market Share by Revenue
2.8.3 Global Irreversible Electroporation (IRE) Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Irreversible Electroporation (IRE) Market Scenario by Region
3.1 Global Irreversible Electroporation (IRE) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Irreversible Electroporation (IRE) Sales by Region: 2020-2031
3.2.1 Global Irreversible Electroporation (IRE) Sales by Region: 2020-2025
3.2.2 Global Irreversible Electroporation (IRE) Sales by Region: 2026-2031
3.3 Global Irreversible Electroporation (IRE) Revenue by Region: 2020-2031
3.3.1 Global Irreversible Electroporation (IRE) Revenue by Region: 2020-2025
3.3.2 Global Irreversible Electroporation (IRE) Revenue by Region: 2026-2031
3.4 North America Irreversible Electroporation (IRE) Market Facts & Figures by Country
3.4.1 North America Irreversible Electroporation (IRE) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Irreversible Electroporation (IRE) Sales by Country (2020-2031)
3.4.3 North America Irreversible Electroporation (IRE) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Irreversible Electroporation (IRE) Market Facts & Figures by Country
3.5.1 Europe Irreversible Electroporation (IRE) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Irreversible Electroporation (IRE) Sales by Country (2020-2031)
3.5.3 Europe Irreversible Electroporation (IRE) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Irreversible Electroporation (IRE) Market Facts & Figures by Region
3.6.1 Asia Pacific Irreversible Electroporation (IRE) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Irreversible Electroporation (IRE) Sales by Region (2020-2031)
3.6.3 Asia Pacific Irreversible Electroporation (IRE) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Irreversible Electroporation (IRE) Market Facts & Figures by Country
3.7.1 Latin America Irreversible Electroporation (IRE) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Irreversible Electroporation (IRE) Sales by Country (2020-2031)
3.7.3 Latin America Irreversible Electroporation (IRE) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Irreversible Electroporation (IRE) Market Facts & Figures by Country
3.8.1 Middle East and Africa Irreversible Electroporation (IRE) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Irreversible Electroporation (IRE) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Irreversible Electroporation (IRE) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Irreversible Electroporation (IRE) Sales by Type (2020-2031)
4.1.1 Global Irreversible Electroporation (IRE) Sales by Type (2020-2025)
4.1.2 Global Irreversible Electroporation (IRE) Sales by Type (2026-2031)
4.1.3 Global Irreversible Electroporation (IRE) Sales Market Share by Type (2020-2031)
4.2 Global Irreversible Electroporation (IRE) Revenue by Type (2020-2031)
4.2.1 Global Irreversible Electroporation (IRE) Revenue by Type (2020-2025)
4.2.2 Global Irreversible Electroporation (IRE) Revenue by Type (2026-2031)
4.2.3 Global Irreversible Electroporation (IRE) Revenue Market Share by Type (2020-2031)
4.3 Global Irreversible Electroporation (IRE) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Irreversible Electroporation (IRE) Sales by Application (2020-2031)
5.1.1 Global Irreversible Electroporation (IRE) Sales by Application (2020-2025)
5.1.2 Global Irreversible Electroporation (IRE) Sales by Application (2026-2031)
5.1.3 Global Irreversible Electroporation (IRE) Sales Market Share by Application (2020-2031)
5.2 Global Irreversible Electroporation (IRE) Revenue by Application (2020-2031)
5.2.1 Global Irreversible Electroporation (IRE) Revenue by Application (2020-2025)
5.2.2 Global Irreversible Electroporation (IRE) Revenue by Application (2026-2031)
5.2.3 Global Irreversible Electroporation (IRE) Revenue Market Share by Application (2020-2031)
5.3 Global Irreversible Electroporation (IRE) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AngioDynamics
6.1.1 AngioDynamics Company Information
6.1.2 AngioDynamics Description and Business Overview
6.1.3 AngioDynamics Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AngioDynamics Irreversible Electroporation (IRE) Product Portfolio
6.1.5 AngioDynamics Recent Developments/Updates
6.2 Pulse Biosciences
6.2.1 Pulse Biosciences Company Information
6.2.2 Pulse Biosciences Description and Business Overview
6.2.3 Pulse Biosciences Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pulse Biosciences Irreversible Electroporation (IRE) Product Portfolio
6.2.5 Pulse Biosciences Recent Developments/Updates
6.3 Biosense Webster (J&J)
6.3.1 Biosense Webster (J&J) Company Information
6.3.2 Biosense Webster (J&J) Description and Business Overview
6.3.3 Biosense Webster (J&J) Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Biosense Webster (J&J) Irreversible Electroporation (IRE) Product Portfolio
6.3.5 Biosense Webster (J&J) Recent Developments/Updates
6.4 Medtronic
6.4.1 Medtronic Company Information
6.4.2 Medtronic Description and Business Overview
6.4.3 Medtronic Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Medtronic Irreversible Electroporation (IRE) Product Portfolio
6.4.5 Medtronic Recent Developments/Updates
6.5 Boston Scientific
6.5.1 Boston Scientific Company Information
6.5.2 Boston Scientific Description and Business Overview
6.5.3 Boston Scientific Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Boston Scientific Irreversible Electroporation (IRE) Product Portfolio
6.5.5 Boston Scientific Recent Developments/Updates
6.6 Surgnova
6.6.1 Surgnova Company Information
6.6.2 Surgnova Description and Business Overview
6.6.3 Surgnova Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Surgnova Irreversible Electroporation (IRE) Product Portfolio
6.6.5 Surgnova Recent Developments/Updates
6.7 Nortion REMD
6.7.1 Nortion REMD Company Information
6.7.2 Nortion REMD Description and Business Overview
6.7.3 Nortion REMD Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Nortion REMD Irreversible Electroporation (IRE) Product Portfolio
6.7.5 Nortion REMD Recent Developments/Updates
6.8 Tianjin Alp Medical Technology
6.8.1 Tianjin Alp Medical Technology Company Information
6.8.2 Tianjin Alp Medical Technology Description and Business Overview
6.8.3 Tianjin Alp Medical Technology Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Tianjin Alp Medical Technology Irreversible Electroporation (IRE) Product Portfolio
6.8.5 Tianjin Alp Medical Technology Recent Developments/Updates
6.9 Sichuan Jinjiang Electronic Medical Device Technology
6.9.1 Sichuan Jinjiang Electronic Medical Device Technology Company Information
6.9.2 Sichuan Jinjiang Electronic Medical Device Technology Description and Business Overview
6.9.3 Sichuan Jinjiang Electronic Medical Device Technology Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Sichuan Jinjiang Electronic Medical Device Technology Irreversible Electroporation (IRE) Product Portfolio
6.9.5 Sichuan Jinjiang Electronic Medical Device Technology Recent Developments/Updates
6.10 Tianjin Intelligent Health Medical
6.10.1 Tianjin Intelligent Health Medical Company Information
6.10.2 Tianjin Intelligent Health Medical Description and Business Overview
6.10.3 Tianjin Intelligent Health Medical Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Tianjin Intelligent Health Medical Irreversible Electroporation (IRE) Product Portfolio
6.10.5 Tianjin Intelligent Health Medical Recent Developments/Updates
6.11 Shineyo Medical
6.11.1 Shineyo Medical Company Information
6.11.2 Shineyo Medical Description and Business Overview
6.11.3 Shineyo Medical Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Shineyo Medical Irreversible Electroporation (IRE) Product Portfolio
6.11.5 Shineyo Medical Recent Developments/Updates
6.12 Zhouling Medical Equipment
6.12.1 Zhouling Medical Equipment Company Information
6.12.2 Zhouling Medical Equipment Description and Business Overview
6.12.3 Zhouling Medical Equipment Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Zhouling Medical Equipment Irreversible Electroporation (IRE) Product Portfolio
6.12.5 Zhouling Medical Equipment Recent Developments/Updates
6.13 Aikemai Medical Equipment
6.13.1 Aikemai Medical Equipment Company Information
6.13.2 Aikemai Medical Equipment Description and Business Overview
6.13.3 Aikemai Medical Equipment Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Aikemai Medical Equipment Irreversible Electroporation (IRE) Product Portfolio
6.13.5 Aikemai Medical Equipment Recent Developments/Updates
6.14 Hangzhou Nuomao Medical Technology
6.14.1 Hangzhou Nuomao Medical Technology Company Information
6.14.2 Hangzhou Nuomao Medical Technology Description and Business Overview
6.14.3 Hangzhou Nuomao Medical Technology Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Hangzhou Nuomao Medical Technology Irreversible Electroporation (IRE) Product Portfolio
6.14.5 Hangzhou Nuomao Medical Technology Recent Developments/Updates
6.15 APT Medical
6.15.1 APT Medical Company Information
6.15.2 APT Medical Description and Business Overview
6.15.3 APT Medical Irreversible Electroporation (IRE) Sales, Revenue and Gross Margin (2020-2025)
6.15.4 APT Medical Irreversible Electroporation (IRE) Product Portfolio
6.15.5 APT Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Irreversible Electroporation (IRE) Industry Chain Analysis
7.2 Irreversible Electroporation (IRE) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Irreversible Electroporation (IRE) Production Mode & Process Analysis
7.4 Irreversible Electroporation (IRE) Sales and Marketing
7.4.1 Irreversible Electroporation (IRE) Sales Channels
7.4.2 Irreversible Electroporation (IRE) Distributors
7.5 Irreversible Electroporation (IRE) Customer Analysis
8 Irreversible Electroporation (IRE) Market Dynamics
8.1 Irreversible Electroporation (IRE) Industry Trends
8.2 Irreversible Electroporation (IRE) Market Drivers
8.3 Irreversible Electroporation (IRE) Market Challenges
8.4 Irreversible Electroporation (IRE) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Irreversible Electroporation (IRE) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Irreversible Electroporation (IRE) Market Value by Guidance System, (US$ Million) & (2024 VS 2031)
Table 3. Global Irreversible Electroporation (IRE) Market Value by End User, (US$ Million) & (2024 VS 2031)
Table 4. Global Irreversible Electroporation (IRE) Market Value by Application (2024 VS 2031) & (US$ Million)
Table 5. Global Irreversible Electroporation (IRE) Market Competitive Situation by Manufacturers in 2024
Table 6. Global Irreversible Electroporation (IRE) Sales (Units) of Key Manufacturers (2020-2025)
Table 7. Global Irreversible Electroporation (IRE) Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Irreversible Electroporation (IRE) Revenue (US$ Million) by Manufacturers (2020-2025)
Table 9. Global Irreversible Electroporation (IRE) Revenue Share by Manufacturers (2020-2025)
Table 10. Global Market Irreversible Electroporation (IRE) Average Price (K US$/Unit) of Key Manufacturers (2020-2025)
Table 11. Global Key Players of Irreversible Electroporation (IRE), Industry Ranking, 2022 VS 2023 VS 2024
Table 12. Global Key Manufacturers of Irreversible Electroporation (IRE), Manufacturing Sites & Headquarters
Table 13. Global Key Manufacturers of Irreversible Electroporation (IRE), Product Type & Application
Table 14. Global Key Manufacturers of Irreversible Electroporation (IRE), Date of Enter into This Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Irreversible Electroporation (IRE) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irreversible Electroporation (IRE) as of 2024)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Irreversible Electroporation (IRE) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 19. Global Irreversible Electroporation (IRE) Sales by Region (2020-2025) & (Units)
Table 20. Global Irreversible Electroporation (IRE) Sales Market Share by Region (2020-2025)
Table 21. Global Irreversible Electroporation (IRE) Sales by Region (2026-2031) & (Units)
Table 22. Global Irreversible Electroporation (IRE) Sales Market Share by Region (2026-2031)
Table 23. Global Irreversible Electroporation (IRE) Revenue by Region (2020-2025) & (US$ Million)
Table 24. Global Irreversible Electroporation (IRE) Revenue Market Share by Region (2020-2025)
Table 25. Global Irreversible Electroporation (IRE) Revenue by Region (2026-2031) & (US$ Million)
Table 26. Global Irreversible Electroporation (IRE) Revenue Market Share by Region (2026-2031)
Table 27. North America Irreversible Electroporation (IRE) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. North America Irreversible Electroporation (IRE) Sales by Country (2020-2025) & (Units)
Table 29. North America Irreversible Electroporation (IRE) Sales by Country (2026-2031) & (Units)
Table 30. North America Irreversible Electroporation (IRE) Revenue by Country (2020-2025) & (US$ Million)
Table 31. North America Irreversible Electroporation (IRE) Revenue by Country (2026-2031) & (US$ Million)
Table 32. Europe Irreversible Electroporation (IRE) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 33. Europe Irreversible Electroporation (IRE) Sales by Country (2020-2025) & (Units)
Table 34. Europe Irreversible Electroporation (IRE) Sales by Country (2026-2031) & (Units)
Table 35. Europe Irreversible Electroporation (IRE) Revenue by Country (2020-2025) & (US$ Million)
Table 36. Europe Irreversible Electroporation (IRE) Revenue by Country (2026-2031) & (US$ Million)
Table 37. Asia Pacific Irreversible Electroporation (IRE) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 38. Asia Pacific Irreversible Electroporation (IRE) Sales by Region (2020-2025) & (Units)
Table 39. Asia Pacific Irreversible Electroporation (IRE) Sales by Region (2026-2031) & (Units)
Table 40. Asia Pacific Irreversible Electroporation (IRE) Revenue by Region (2020-2025) & (US$ Million)
Table 41. Asia Pacific Irreversible Electroporation (IRE) Revenue by Region (2026-2031) & (US$ Million)
Table 42. Latin America Irreversible Electroporation (IRE) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Latin America Irreversible Electroporation (IRE) Sales by Country (2020-2025) & (Units)
Table 44. Latin America Irreversible Electroporation (IRE) Sales by Country (2026-2031) & (Units)
Table 45. Latin America Irreversible Electroporation (IRE) Revenue by Country (2020-2025) & (US$ Million)
Table 46. Latin America Irreversible Electroporation (IRE) Revenue by Country (2026-2031) & (US$ Million)
Table 47. Middle East and Africa Irreversible Electroporation (IRE) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 48. Middle East and Africa Irreversible Electroporation (IRE) Sales by Country (2020-2025) & (Units)
Table 49. Middle East and Africa Irreversible Electroporation (IRE) Sales by Country (2026-2031) & (Units)
Table 50. Middle East and Africa Irreversible Electroporation (IRE) Revenue by Country (2020-2025) & (US$ Million)
Table 51. Middle East and Africa Irreversible Electroporation (IRE) Revenue by Country (2026-2031) & (US$ Million)
Table 52. Global Irreversible Electroporation (IRE) Sales (Units) by Type (2020-2025)
Table 53. Global Irreversible Electroporation (IRE) Sales (Units) by Type (2026-2031)
Table 54. Global Irreversible Electroporation (IRE) Sales Market Share by Type (2020-2025)
Table 55. Global Irreversible Electroporation (IRE) Sales Market Share by Type (2026-2031)
Table 56. Global Irreversible Electroporation (IRE) Revenue (US$ Million) by Type (2020-2025)
Table 57. Global Irreversible Electroporation (IRE) Revenue (US$ Million) by Type (2026-2031)
Table 58. Global Irreversible Electroporation (IRE) Revenue Market Share by Type (2020-2025)
Table 59. Global Irreversible Electroporation (IRE) Revenue Market Share by Type (2026-2031)
Table 60. Global Irreversible Electroporation (IRE) Price (K US$/Unit) by Type (2020-2025)
Table 61. Global Irreversible Electroporation (IRE) Price (K US$/Unit) by Type (2026-2031)
Table 62. Global Irreversible Electroporation (IRE) Sales (Units) by Application (2020-2025)
Table 63. Global Irreversible Electroporation (IRE) Sales (Units) by Application (2026-2031)
Table 64. Global Irreversible Electroporation (IRE) Sales Market Share by Application (2020-2025)
Table 65. Global Irreversible Electroporation (IRE) Sales Market Share by Application (2026-2031)
Table 66. Global Irreversible Electroporation (IRE) Revenue (US$ Million) by Application (2020-2025)
Table 67. Global Irreversible Electroporation (IRE) Revenue (US$ Million) by Application (2026-2031)
Table 68. Global Irreversible Electroporation (IRE) Revenue Market Share by Application (2020-2025)
Table 69. Global Irreversible Electroporation (IRE) Revenue Market Share by Application (2026-2031)
Table 70. Global Irreversible Electroporation (IRE) Price (K US$/Unit) by Application (2020-2025)
Table 71. Global Irreversible Electroporation (IRE) Price (K US$/Unit) by Application (2026-2031)
Table 72. AngioDynamics Company Information
Table 73. AngioDynamics Description and Business Overview
Table 74. AngioDynamics Irreversible Electroporation (IRE) Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 75. AngioDynamics Irreversible Electroporation (IRE) Product
Table 76. AngioDynamics Recent Developments/Updates
Table 77. Pulse Biosciences Company Information
Table 78. Pulse Biosciences Description and Business Overview
Table 79. Pulse Biosciences Irreversible Electroporation (IRE) Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 80. Pulse Biosciences Irreversible Electroporation (IRE) Product
Table 81. Pulse Biosciences Recent Developments/Updates
Table 82. Biosense Webster (J&J) Company Information
Table 83. Biosense Webster (J&J) Description and Business Overview
Table 84. Biosense Webster (J&J) Irreversible Electroporation (IRE) Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 85. Biosense Webster (J&J) Irreversible Electroporation (IRE) Product
Table 86. Biosense Webster (J&J) Recent Developments/Updates
Table 87. Medtronic Company Information
Table 88. Medtronic Description and Business Overview
Table 89. Medtronic Irreversible Electroporation (IRE) Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 90. Medtronic Irreversible Electroporation (IRE) Product
Table 91. Medtronic Recent Developments/Updates
Table 92. Boston Scientific Company Information
Table 93. Boston Scientific Description and Business Overview
Table 94. Boston Scientific Irreversible Electroporation (IRE) Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 95. Boston Scientific Irreversible Electroporation (IRE) Product
Table 96. Boston Scientific Recent Developments/Updates
Table 97. Surgnova Company Information
Table 98. Surgnova Description and Business Overview
Table 99. Surgnova Irreversible Electroporation (IRE) Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 100. Surgnova Irreversible Electroporation (IRE) Product
Table 101. Surgnova Recent Developments/Updates
Table 102. Nortion REMD Company Information
Table 103. Nortion REMD Description and Business Overview
Table 104. Nortion REMD Irreversible Electroporation (IRE) Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 105. Nortion REMD Irreversible Electroporation (IRE) Product
Table 106. Nortion REMD Recent Developments/Updates
Table 107. Tianjin Alp Medical Technology Company Information
Table 108. Tianjin Alp Medical Technology Description and Business Overview
Table 109. Tianjin Alp Medical Technology Irreversible Electroporation (IRE) Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 110. Tianjin Alp Medical Technology Irreversible Electroporation (IRE) Product
Table 111. Tianjin Alp Medical Technology Recent Developments/Updates
Table 112. Sichuan Jinjiang Electronic Medical Device Technology Company Information
Table 113. Sichuan Jinjiang Electronic Medical Device Technology Description and Business Overview
Table 114. Sichuan Jinjiang Electronic Medical Device Technology Irreversible Electroporation (IRE) Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 115. Sichuan Jinjiang Electronic Medical Device Technology Irreversible Electroporation (IRE) Product
Table 116. Sichuan Jinjiang Electronic Medical Device Technology Recent Developments/Updates
Table 117. Tianjin Intelligent Health Medical Company Information
Table 118. Tianjin Intelligent Health Medical Description and Business Overview
Table 119. Tianjin Intelligent Health Medical Irreversible Electroporation (IRE) Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 120. Tianjin Intelligent Health Medical Irreversible Electroporation (IRE) Product
Table 121. Tianjin Intelligent Health Medical Recent Developments/Updates
Table 122. Shineyo Medical Company Information
Table 123. Shineyo Medical Description and Business Overview
Table 124. Shineyo Medical Irreversible Electroporation (IRE) Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 125. Shineyo Medical Irreversible Electroporation (IRE) Product
Table 126. Shineyo Medical Recent Developments/Updates
Table 127. Zhouling Medical Equipment Company Information
Table 128. Zhouling Medical Equipment Description and Business Overview
Table 129. Zhouling Medical Equipment Irreversible Electroporation (IRE) Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 130. Zhouling Medical Equipment Irreversible Electroporation (IRE) Product
Table 131. Zhouling Medical Equipment Recent Developments/Updates
Table 132. Aikemai Medical Equipment Company Information
Table 133. Aikemai Medical Equipment Description and Business Overview
Table 134. Aikemai Medical Equipment Irreversible Electroporation (IRE) Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 135. Aikemai Medical Equipment Irreversible Electroporation (IRE) Product
Table 136. Aikemai Medical Equipment Recent Developments/Updates
Table 137. Hangzhou Nuomao Medical Technology Company Information
Table 138. Hangzhou Nuomao Medical Technology Description and Business Overview
Table 139. Hangzhou Nuomao Medical Technology Irreversible Electroporation (IRE) Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 140. Hangzhou Nuomao Medical Technology Irreversible Electroporation (IRE) Product
Table 141. Hangzhou Nuomao Medical Technology Recent Developments/Updates
Table 142. APT Medical Company Information
Table 143. APT Medical Description and Business Overview
Table 144. APT Medical Irreversible Electroporation (IRE) Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 145. APT Medical Irreversible Electroporation (IRE) Product
Table 146. APT Medical Recent Developments/Updates
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Irreversible Electroporation (IRE) Distributors List
Table 150. Irreversible Electroporation (IRE) Customers List
Table 151. Irreversible Electroporation (IRE) Market Trends
Table 152. Irreversible Electroporation (IRE) Market Drivers
Table 153. Irreversible Electroporation (IRE) Market Challenges
Table 154. Irreversible Electroporation (IRE) Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
Table 158. Authors List of This Report
List of Figures
Figure 1. Product Picture of Irreversible Electroporation (IRE)
Figure 2. Global Irreversible Electroporation (IRE) Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Irreversible Electroporation (IRE) Market Share by Type: 2024 & 2031
Figure 4. IRE Devices Product Picture
Figure 5. IRE Catheters Product Picture
Figure 6. Global Irreversible Electroporation (IRE) Market Value by Guidance System, (US$ Million) & (2020-2031)
Figure 7. Global Irreversible Electroporation (IRE) Market Share by Guidance System: 2024 VS 2031
Figure 8. 2D Guidance Product Picture
Figure 9. 3D Guidance Product Picture
Figure 10. Global Irreversible Electroporation (IRE) Market Value by End User, (US$ Million) & (2020-2031)
Figure 11. Global Irreversible Electroporation (IRE) Market Share by End User: 2024 VS 2031
Figure 12. Hospitals Product Picture
Figure 13. Ambulatory Surgical Centers Product Picture
Figure 14. Global Irreversible Electroporation (IRE) Market Value by Application (2020-2031) & (US$ Million)
Figure 15. Global Irreversible Electroporation (IRE) Market Share by Application: 2024 & 2031
Figure 16. Tumors
Figure 17. Cardiac Diseases
Figure 18. Global Irreversible Electroporation (IRE) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Irreversible Electroporation (IRE) Market Size (2020-2031) & (US$ Million)
Figure 20. Global Irreversible Electroporation (IRE) Sales (2020-2031) & (Units)
Figure 21. Global Irreversible Electroporation (IRE) Average Price (K US$/Unit) & (2020-2031)
Figure 22. Irreversible Electroporation (IRE) Report Years Considered
Figure 23. Irreversible Electroporation (IRE) Sales Share by Manufacturers in 2024
Figure 24. Global Irreversible Electroporation (IRE) Revenue Share by Manufacturers in 2024
Figure 25. Global 5 and 10 Largest Irreversible Electroporation (IRE) Players: Market Share by Revenue in Irreversible Electroporation (IRE) in 2024
Figure 26. Irreversible Electroporation (IRE) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 27. Global Irreversible Electroporation (IRE) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 28. North America Irreversible Electroporation (IRE) Sales Market Share by Country (2020-2031)
Figure 29. North America Irreversible Electroporation (IRE) Revenue Market Share by Country (2020-2031)
Figure 30. United States Irreversible Electroporation (IRE) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Canada Irreversible Electroporation (IRE) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Europe Irreversible Electroporation (IRE) Sales Market Share by Country (2020-2031)
Figure 33. Europe Irreversible Electroporation (IRE) Revenue Market Share by Country (2020-2031)
Figure 34. Germany Irreversible Electroporation (IRE) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. France Irreversible Electroporation (IRE) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. U.K. Irreversible Electroporation (IRE) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Italy Irreversible Electroporation (IRE) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Russia Irreversible Electroporation (IRE) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Asia Pacific Irreversible Electroporation (IRE) Sales Market Share by Region (2020-2031)
Figure 40. Asia Pacific Irreversible Electroporation (IRE) Revenue Market Share by Region (2020-2031)
Figure 41. China Irreversible Electroporation (IRE) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Japan Irreversible Electroporation (IRE) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. South Korea Irreversible Electroporation (IRE) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. India Irreversible Electroporation (IRE) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Australia Irreversible Electroporation (IRE) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. China Taiwan Irreversible Electroporation (IRE) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Southeast Asia Irreversible Electroporation (IRE) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Latin America Irreversible Electroporation (IRE) Sales Market Share by Country (2020-2031)
Figure 49. Latin America Irreversible Electroporation (IRE) Revenue Market Share by Country (2020-2031)
Figure 50. Mexico Irreversible Electroporation (IRE) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Brazil Irreversible Electroporation (IRE) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Argentina Irreversible Electroporation (IRE) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Colombia Irreversible Electroporation (IRE) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Middle East and Africa Irreversible Electroporation (IRE) Sales Market Share by Country (2020-2031)
Figure 55. Middle East and Africa Irreversible Electroporation (IRE) Revenue Market Share by Country (2020-2031)
Figure 56. Turkey Irreversible Electroporation (IRE) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Saudi Arabia Irreversible Electroporation (IRE) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. UAE Irreversible Electroporation (IRE) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. Global Sales Market Share of Irreversible Electroporation (IRE) by Type (2020-2031)
Figure 60. Global Revenue Market Share of Irreversible Electroporation (IRE) by Type (2020-2031)
Figure 61. Global Irreversible Electroporation (IRE) Price (K US$/Unit) by Type (2020-2031)
Figure 62. Global Sales Market Share of Irreversible Electroporation (IRE) by Application (2020-2031)
Figure 63. Global Revenue Market Share of Irreversible Electroporation (IRE) by Application (2020-2031)
Figure 64. Global Irreversible Electroporation (IRE) Price (K US$/Unit) by Application (2020-2031)
Figure 65. Irreversible Electroporation (IRE) Value Chain
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
